|
|
7786 Wiles Road
Coral Springs, FL 33067 USA
phone:954-741-7077
fax:954-741-7021
|
|
| Symbol |
CYGE.PK |
| Exchange |
PNK |
| Founded |
1995 |
| Employees |
|
|
|
| www.cygenelabs.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Biotechnology DNA/RNA, proteomic, chemical and cellular detection technologies. |
|
| Management |
| Martin Munzer, President and Chief Executive Officer; Barry H. Dvorchik, Vice President, Drug Development; Peter J. Laurence, Vice President, Business Delevopment; Dr. Jeffrey Pinco, Laboratory Director; Martin Jorge Lpez Cordova, R&D Laboratory Director USA; Richard A. Chmelo, Director of Genetic Profiling Services |
| |
|
|
|
|
|
|
|
| Keywords |
| blood screening tests for the West Nile Virus and other infectious diseases, as well as the detection of biological warfare agents., InfectiousDisease |
|
|
|
| Description |
|
CyGene, Inc. recently executed a definitive merger agreement merger with Transpirator Technologies, Inc. (OTC BB:TPRT). As a result, The Company will change its name to CyGene Laboratories Inc., and trade under a new symbol "CYGE". CyGene, Inc., based in Coral Springs, Florida, is poised to begin marketing low cost commercialized genetic testing to the public. Since 1995 the company has been developing proprietary and automated DNA and RNA testing systems for the screening, monitoring and diagnosis of human, veterinary and plant diseases. CyGene's primary development focus is in blood screening tests for the West Nile Virus and other infectious diseases, as well as the detection of biological warfare agents. The company's technology portfolio also includes two development stage drugs, one for gene therapy by way of antisense. Please visit http://www.cygene.com/. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
